Christopher Horan, Chief Technology Operations Officer at Artiva Biotherapeutics, Inc. (ARTV), sold 10,340 shares at $6.84 ($71K) on 2026-10-05, disclosed to the SEC on 2026-10-06.
Open-market sale of $71k ARTV by Chief Technology Operations Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.